In 2023, the FDA designated BPC-157 as a Category 2 bulk drug substance, meaning it cannot be compounded by licensed pharmacies due to insufficient human safety data
Similarly, in the Phase I trial, two participants in the 5 10 6 cells/injection group experienced grade 1 adverse events (gum swelling and diarrhea) that may have been related to the injection
Known for her warm personality and genuine desire to help others, Eshara is committed to making a positive impact both inside and outside the clinic
When the Panel Reviewing Peptides Profits From Them Before Friday's vote even occurs, the composition of the committee itself has drawn sharp criticism
Children with these conditions often exhibit sudden-onset obsessive compulsive disorder (OCD), tics, rage episodes, and severe separation anxiety following a strep or other infectious trigger